Product Description
Capitalise on the prodigious therapeutic potential of TEPAPINE 15MG THIOTEPA INJECTION, your top-ranking antineoplastic solution for hospital use. With a venerable history in cancer care, especially breast cancer, this lyophilized cytotoxic agent delivers sizzling efficacy, packed in single vials for intravenous administration. Available in IP 15 mg strength (KKD5S), each vial ensures trusted quality and precision dosing. Manufactured and exported by a leading supplier in India, our impressive capacity of 10,000 units guarantees availability, making every purchase a true bargain in oncology treatment.
Widely Recognized Commercial Uses and Specific Application
TEPAPINE 15MG THIOTEPA INJECTION is specifically indicated for the treatment of various malignancies, with an established role in breast cancer therapy. Hospital professionals and oncology centers widely use this prodigious lyophilized injectable for intravenous administration due to its potent cytotoxic effect. Its general use as an anti-cancer agent offers clinicians versatility in cancer protocols, while its specific strength and purity deliver reliable results across numerous cancer types. This product remains prescription-only to ensure patient safety and precise dosing.
Efficient Delivery, Packaging, and Purchase Policy
TEPAPINE 15MG THIOTEPA INJECTION is supplied with streamlined delivery to hospitals and clinics, ensuring rapid replenishment even at the lowest price point for bulk orders. Each purchase order is met with prompt dispatch in secure, single-vial packaging to preserve product integrity. Sample policies may be available to institutional buyers, with packaging designed to guarantee stability during refrigerated transport. Our flexible approach ensures timely access to this critical anti-cancer agent for all professional clients.
FAQ's of TEPAPINE 15MG THIOTEPA INJECTION:
Q: How should TEPAPINE 15MG THIOTEPA INJECTION be administered?
A: This medication must be administered intravenously by qualified healthcare professionals within a hospital setting in accordance with prescription guidelines.
Q: What are the primary clinical uses of TEPAPINE 15MG THIOTEPA INJECTION?
A: TEPAPINE 15MG THIOTEPA INJECTION is primarily indicated for cancer treatment, especially for breast cancer and other malignancies suitable for thiotepa-based intervention.
Q: When can bulk orders be fulfilled for this product?
A: With a production capacity of 10,000 units, bulk purchase orders can be fulfilled quickly, adhering to delivery timelines arranged at the time of procurement.
Q: Where should TEPAPINE 15MG THIOTEPA INJECTION be stored upon receipt?
A: The product must be stored in a refrigerator at 2-8C immediately after receipt to maintain its potency and stability.
Q: What are the packaging details for TEPAPINE 15MG THIOTEPA INJECTION?
A: Each vial is individually packaged in a secure box to ensure hygiene and product safety during transit and storage.
Q: How does TEPAPINE 15MG THIOTEPA INJECTION benefit oncology treatment protocols?
A: By acting as a potent anti-cancer cytotoxic agent, TEPAPINE 15MG THIOTEPA supports high-efficacy regimens in various oncology protocols, ensuring targeted and effective cancer cell suppression.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese